Gemeinsam für hohe Standards bei der Bewertung von Gesundheitstechnolo-gien in Europa ab 2025
Wenige Monate vor Inkrafttreten der EU-HTA-Verordnung besuchte eine Delegation der französi-schen HTA-Agentur HAS das IQWiG in Köln, um sich über die Zukunft der europäischen Nutzenbe-wertung auszutauschen.
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/wDIXxMy
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.